XANTERA Trademark

Trademark Overview

On Thursday, September 16, 2004, a trademark application was filed for XANTERA with the United States Patent and Trademark Office. The USPTO has given the XANTERA trademark a serial number of 79006360. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 17, 2014. This trademark is owned by Santhera Pharmaceuticals AG. The XANTERA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development of pharmaceutical preparations; scientific research and development of new technology in the field of medicine; research and analysis in the field of medicine
xantera

General Information

Serial Number79006360
Word MarkXANTERA
Filing DateThursday, September 16, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, September 17, 2014
Registration Number3059191
Registration DateTuesday, February 14, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2005

Trademark Statements

Goods and ServicesScientific research and development of pharmaceutical preparations; scientific research and development of new technology in the field of medicine; research and analysis in the field of medicine

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 6, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanthera Pharmaceuticals Holding AG
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressCH
Party NameSanthera Pharmaceuticals AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameSanthera Pharmaceuticals AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameSanthera Pharmaceuticals AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Friday, April 3, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, April 3, 2015DEATH OF INTERNATIONAL REGISTRATION
Friday, October 10, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, August 14, 2014TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, May 6, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 6, 2013CANCELLED SECTION 71
Monday, July 18, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, July 2, 2010REVIEW OF CORRESPONDENCE COMPLETE
Friday, July 2, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 19, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 19, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 13, 2010PAPER RECEIVED
Friday, October 19, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 29, 2006FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 29, 2006FINAL DISPOSITION PROCESSED
Thursday, September 14, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, August 17, 2006CHANGE OF OWNER RECEIVED FROM IB
Tuesday, February 14, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, November 22, 2005PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2005NOTICE OF PUBLICATION
Monday, October 3, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 30, 2005ASSIGNED TO LIE
Wednesday, September 28, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, September 21, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 21, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 16, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 16, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 2, 2005REFUSAL PROCESSED BY IB
Wednesday, April 20, 2005NON-FINAL ACTION MAILED
Monday, April 18, 2005NON-FINAL ACTION WRITTEN
Friday, April 15, 2005ASSIGNED TO EXAMINER
Friday, December 3, 2004NEW APPLICATION ENTERED IN TRAM
Thursday, December 2, 2004SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

xantera research medicine scientific development field analysis preparations pharmaceutical technology